Literature DB >> 7474162

The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors.

D J Anderson1, J Stone, R Lum, M L Linial.   

Abstract

The avian packaging cell line SE21Q1b produces particles which encapsidate cellular RNAs. Such RNAs can be reverse transcribed by endogenous polymerase and integrated into the genomes of newly infected cells (M. Linial, Cell 49:93-102, 1987). Genomic RNA is not packaged because the packaging (psi) region of the provirus is deleted. The provirus also lacks the negative-strand primer binding site, which prevents efficient reverse transcription of randomly packaged genomic RNA. Previous work from our laboratory suggested that the trans-acting defect which allows packaging of cellular mRNA mapped to the provirus but did not map to the nucleocapsid region of the gag gene (D.J. Anderson, P. Lee, K. L. Levine, J. Sang, S. A. Shah, O. O. Yang, P. R. Shank, and M. L. Linial, J. Virol. 66:204-216, 1992). We have found, using proviral recombinants between SE21Q1b and wild-type Rous sarcoma virus, that packaging of cellular RNAs does not map to the gag gene. Rather, the propensity of SE21Q1b particles to package cellular mRNA is a function of the high level of particle production in these cells and not of any specific viral structural proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474162      PMCID: PMC189662     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Development of avian sarcoma and leukosis virus-based vector-packaging cell lines.

Authors:  A W Stoker; M J Bissell
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Retroviral RNA packaging: sequence requirements and implications.

Authors:  M L Linial; A D Miller
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Generation of a helper cell line for packaging avian leukosis virus-based vectors.

Authors:  P Savatier; C Bagnis; P Thoraval; D Poncet; M Belakebi; F Mallet; C Legras; F L Cosset; J L Thomas; Y Chebloune
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Creation of a processed pseudogene by retroviral infection.

Authors:  M Linial
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

6.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

Authors:  D W Cleveland; M A Lopata; R J MacDonald; N J Cowan; W J Rutter; M W Kirschner
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

9.  At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses.

Authors:  H L Robinson; B M Blais; P N Tsichlis; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.

Authors:  V W Wilkerson; D L Bryant; J T Parsons
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more
  10 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Retrotransposition of nonviral RNAs in an avian packaging cell line.

Authors:  R Lum; M L Linial
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector.

Authors:  G Sun; P K O'Neil; H Yu; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro.

Authors:  Ya-Xiong Feng; Tong Li; Stephen Campbell; Alan Rein
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.

Authors:  E g Lee; A Yeo; B Kraemer; M Wickens; M L Linial
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  cis-Acting elements important for retroviral RNA packaging specificity.

Authors:  Benjamin E Beasley; Wei-Shau Hu
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1.

Authors:  Pavlina Konstantinova; Peter de Haan; Atze T Das; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2006-05-02       Impact factor: 16.971

10.  RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA.

Authors:  Breanna L Rice; Timothy L Lochmann; Leslie J Parent
Journal:  Viruses       Date:  2020-03-27       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.